Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

General Information and Reorganization Transaction - Additional Information (Details)

v3.22.2
General Information and Reorganization Transaction - Additional Information (Details) - USD ($)
 12 Months Ended
Jul. 02, 2021
Mar. 31, 2022
Mar. 31, 2021
Sep. 20, 2021
Sep. 02, 2021
Jun. 25, 2021
Jun. 24, 2021
Apr. 30, 2021
Feb. 26, 2021
Apr. 30, 2020
Disclosure of reclassifications or changes in presentation [line items]                    
Number of shares outstanding         102,952,766         20
Number of shares issued         102,952,766 3,367,409 19,111,119 80,000,000    
Percentage of shares acquire             95.65%      
Conversion of stock shares exchanged       102,478,548            
Accumulated deficit   $ 6,336,966 $ 4,628,139              
Net loss   $ 1,749,870 $ 672,915              
Class A Shares                    
Disclosure of reclassifications or changes in presentation [line items]                    
Conversion of stock shares exchanged       2,556,575            
Class B Shares                    
Disclosure of reclassifications or changes in presentation [line items]                    
Conversion of stock shares exchanged       7,026,759            
Virax Biolabs Group Limited                    
Disclosure of reclassifications or changes in presentation [line items]                    
Date of incoporation   Sep. 02, 2021                
Virax Biolabs (UK) Limited                    
Disclosure of reclassifications or changes in presentation [line items]                    
Date of incoporation   Aug. 19, 2021                
Virax Biolabs HKCo Limited                    
Disclosure of reclassifications or changes in presentation [line items]                    
Date of incoporation   Apr. 14, 2020                
Virax Immune T- Cell Medical Device Company Limited                    
Disclosure of reclassifications or changes in presentation [line items]                    
Date of incoporation   Jan. 16, 2017                
Virax Biolabs Pte. Limited                    
Disclosure of reclassifications or changes in presentation [line items]                    
Date of incoporation   May 04, 2013                
Number of shares issued     621,795           581,083  
Virax Biolabs Limited                    
Disclosure of reclassifications or changes in presentation [line items]                    
Percentage of capital owned 95.65%                  
Third Party Shareholders                    
Disclosure of reclassifications or changes in presentation [line items]                    
Percentage of capital owned 4.35%                  
Logico Bioproduct Corp                    
Disclosure of reclassifications or changes in presentation [line items]                    
Date of incoporation   Jan. 21, 2011                
Shanghai Xitu Consulting Co., Limited                    
Disclosure of reclassifications or changes in presentation [line items]                    
Date of incoporation   Oct. 27, 2017